Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Los Angeles Institute for Metabolic Research (LA-IMR) is a specialized clinical research center dedicated to the development of innovative treatments for metabolic diseases, including diabetes, obesity, and liver disorders. Led by Dr. Juan Pablo Frias, a world-renowned endocrinologist and clinical investigator, the institute conducts Phase 1b through Phase 4 clinical trials for global pharmaceutical and biotechnology sponsors. LA-IMR operates a state-of-the-art facility in downtown Los Angeles, providing expertise in complex metabolic procedures such as automated glucose clamps and advanced imaging. The center is a key participant in landmark trials for next-generation therapies, including GLP-1, GIP, and glucagon receptor agonists. By combining scientific excellence with compassionate patient care, LA-IMR serves as a vital link in the advancement of cardiometabolic medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute For Metabolic Research.